U2

U2

U6

U6

U6

U6

Josefstädter Straße

Alser Straße

Michelbeuern-AKH

Währinger Straße-Volksoper

Rathaus

Schottentor

43

43

4444

44 44 43, 44 43, 44 43, 44

43, 44

37, 38, 40, 41, 42

37, 38, 40, 41, 42, 43, 44

37, 38, 40, 41, 42

37, 38, 40, 41, 42

33, 37, 38, 5

37, 38

33, 5

33, 5

33, 5

37, 38

40, 41, 42

42

40, 41

40, 41

40, 41

42

42

37, 38

33, 5

33, 5

33, 5

33, 5

33, 5

33, 5

33, 533, 5

33, 533, 5

33

W

ährin

ger G

ürtel

Her

nals

er G

ürte

l

Borschkegasse

Lazarettgasse

Sp

italg

asse

Nuß

dor

fer

Str

aße

Sp

italg

asse

Sens

enga

sse

Kinderspitalg.

Währinger Straße

Währinger StraßeSeveringasse

Freyung

Schw

arzsp

anier

str.

Türke

nstraß

e

Van-S

wieten

-G.

Alser Straße

Roo

seve

ltpl.

Sigmund-Freud-ParkUniversitätsstraße

Do

na

uk

an

al

In cooperation with

ContactDepartment of UrologyMedUni Vienna/Vienna General Hospital Waehringer Guertel 18-20, 1090 Vienna, Austria

Phone: +43 (0)1 40400–26150Fax: +43 (0)1 40400–23320E-Mail: shahrokh.shariat@meduniwien.ac.at

www.meduniwien.ac.at/frontiers-in-urology

4th Michael J. Marberger (MJM) Annual Meeting

Frontiers in Urology

14th December 2018, 1.00 pmVan Swieten Saal, Medical University of Vienna

www.meduniwien.ac.at/frontiers-in-urology

DEPARTMENT OF UROLOGY

Van Swieten Saal, Medical University of ViennaVan-Swieten-Gasse 1a1090 Vienna

Silver Partner

Bronze Partner

Copper Partner

Gold Partner

By

-

Program 1.00 – 1.10 pmWelcomeMichael J. Marberger (Em.) and Shahrokh F. Shariat, Medical University of Vienna, Vienna General Hospital, Austria Frans M.J. Debruyne, Andros Mannenkliniek, Arnhem, The Netherlands

1.10 – 2.30 pmSession 1: Frontiers in prostate cancer

Active Surveillance, from Bench to BedsideLaurence Klotz, Sunnybrook Health Sciences Centre, Toronto, Canada

Genomic features of MR visible prostate cancer Ganesh Palapattu, University of Michigan Health System, USA

Lymphadenectomy at radical prostatectomy: when, how and why?Derya Tilki, Martini Clinic and University Medical Center Hamburg-Eppendorf, Germany

Radiomics: a new tool for uro-oncology Romain Mathieu, Rennes University Hospital, France

2.30 – 2.50 pmCoffee break

2.50 – 4.10 pmSession 2: Frontiers in bladder and kidney cancer

En bloc resection of NMIBC: is it here to stay?Dmitry Enikeev, I.M. Sechenov First Moscow State Medical University, Russia

40 years of cisplatin in bladder cancer: any progress yet?Roland Seiler, Uro-Oncology with Prostate Center, University Hospital Inselspital, Bern, Switzerland

Cytoreductive nephrectomy: what is the new standard?Vitaly Margulis, UT Southwestern Medical Center, Dallas, USA

Optimizing outcomes from immunotherapy in mRCCManuela Schmidinger, Medical University of Vienna, Vienna General Hospital, Austria

4.10 – 4.30 pmCoffee break

4.30 – 6.00 pmSession 3: Frontiers in benign urology

Aquablation treatment of BPH: TUR-P 3.0Thorsten Bach, Asklepios Clinic Harburg, Urological Centre Hamburg, Germany

Innovations in urethral surgeryCarlos Llorente, Hospital Fundación de Alcorcón, Madrid, Spain

Post-Prostatectomy incontinence: what to do and in whom?Ricarda Bauer, Urological Clinic and Polyclinic, Ludwig-Maximilians-Universität München, Germany

MJM Lectureship Reducing scientific error and ensuring innovation in urologyLaurence Klotz, Sunnybrook Health Sciences Centre, Toronto, Canada

6.00 pmGoodbye and farewell Michael J. Marberger (Em.), Medical University of Vienna, Vienna General Hospital, Austria Frans M.J. Debruyne, Andros Mannenkliniek, Arnhem, The Netherlands

This event will be approved by the Austrian Medical Chamber with DFP-Points.

Please be aware that photographs and/or video footage will be taken at the event. These may be used for the purpose of documenting or reporting the event and published in print and online media, on various social media platforms and on MedUni Vienna‘s website.

-

The 4th Michael J. Marberger annual meeting is an intensive, interactive, half-day educational program that brings together renowned international experts to discuss Frontiers in Urology 2018. We have been lucky to attract some of the most innovative inter-national guest speakers to discuss the most novel breakthroughs that will shape the care of our urologic patients. The meeting will focus on key clinical topics in the management of urological diseases including prostate cancer, bladder cancer, kidney cancer, BPH, incontinence, and urethral surgery. On December 14, state-of-the art lectures will provide clinicians and scientists with an update of the breakthroughs of 2018 to maintain their high level of care and further optimize their outcomes. At the conclusion of this activity participants should be better prepared to: • Describe the newest methods for diagnosis and

information that can provide the rationale for clinical decision-making

• Summarize recommendations that shape current strategies to care for patients

• Develop multidisciplinary strategies to optimize outcomes for patients

• Assess recent practice-changing clinical trial findings concerning novel tools, compounds or strategies

• Apply emerging clinical concepts to support the management in consideration of evolving treat-ment paradigms in the field

See more at:www.meduniwien.ac.at/frontiers-in-urology